These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15899749)

  • 21. A community-based study to examine the effect of a youth HIV prevention intervention on young people aged 15-24 in South Africa: results of the baseline survey.
    Pettifor AE; Kleinschmidt I; Levin J; Rees HV; MacPhail C; Madikizela-Hlongwa L; Vermaak K; Napier G; Stevens W; Padian NS
    Trop Med Int Health; 2005 Oct; 10(10):971-80. PubMed ID: 16185231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A cluster randomized-controlled trial to determine the effectiveness of Stepping Stones in preventing HIV infections and promoting safer sexual behaviour amongst youth in the rural Eastern Cape, South Africa: trial design, methods and baseline findings.
    Jewkes R; Nduna M; Levin J; Jama N; Dunkle K; Khuzwayo N; Koss M; Puren A; Wood K; Duvvury N
    Trop Med Int Health; 2006 Jan; 11(1):3-16. PubMed ID: 16398750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Barebacking: cost vs benefit analysis.
    Larson P
    Posit Aware; 1999; 10(4):56-8. PubMed ID: 11366809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of HIV prevention strategies in resource-poor countries: tailoring the intervention to the context.
    Wegbreit J; Bertozzi S; DeMaria LM; Padian NS
    AIDS; 2006 Jun; 20(9):1217-35. PubMed ID: 16816550
    [No Abstract]   [Full Text] [Related]  

  • 25. Supporting Positive Living and Sexual Health (SPLASH): a clinician and behavioral counselor risk-reduction intervention in a university-based HIV clinic.
    Zúñiga ML; Baldwin H; Uhler D; Brennan J; Olshefsky AM; Oliver E; Mathews WC
    AIDS Behav; 2007 Sep; 11(5 Suppl):S58-71. PubMed ID: 17587172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The economic analysis of prevention: an illustration involving children's behavior problems.
    Foster EM; Jones DE
    J Ment Health Policy Econ; 2007 Dec; 10(4):165-75. PubMed ID: 18166828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consequences of HIV prevention interventions and programs: spectrum, selection, and quality of outcome measures.
    Holtgrave DR; Pinkerton SD
    AIDS; 2000 Sep; 14 Suppl 2():S27-33. PubMed ID: 11061639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recommendations for incorporating human immunodeficiency virus (HIV) prevention into the medical care of persons living with HIV.
    ; ; ; ;
    Clin Infect Dis; 2004 Jan; 38(1):104-21. PubMed ID: 14679456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of an intervention to prevent depression in at-risk teens.
    Lynch FL; Hornbrook M; Clarke GN; Perrin N; Polen MR; O'Connor E; Dickerson J
    Arch Gen Psychiatry; 2005 Nov; 62(11):1241-8. PubMed ID: 16275811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness and cost-effectiveness of strategies to expand antiretroviral therapy in St. Petersburg, Russia.
    Long EF; Brandeau ML; Galvin CM; Vinichenko T; Tole SP; Schwartz A; Sanders GD; Owens DK
    AIDS; 2006 Nov; 20(17):2207-15. PubMed ID: 17086061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cost-effectiveness of improving malaria home management: shopkeeper training in rural Kenya.
    Goodman CA; Mutemi WM; Baya EK; Willetts A; Marsh V
    Health Policy Plan; 2006 Jul; 21(4):275-88. PubMed ID: 16682433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Processes and outcomes of HIV serostatus disclosure to sexual partners among people living with HIV in Uganda.
    King R; Katuntu D; Lifshay J; Packel L; Batamwita R; Nakayiwa S; Abang B; Babirye F; Lindkvist P; Johansson E; Mermin J; Bunnell R
    AIDS Behav; 2008 Mar; 12(2):232-43. PubMed ID: 17828450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT).
    Atthobari J; Asselbergs FW; Boersma C; de Vries R; Hillege HL; van Gilst WH; Gansevoort RT; de Jong PE; de Jong-van den Berg LT; Postma MJ;
    Clin Ther; 2006 Mar; 28(3):432-44. PubMed ID: 16750458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incremental cost-effectiveness of a collaborative care intervention for panic disorder.
    Katon W; Russo J; Sherbourne C; Stein MB; Craske M; Fan MY; Roy-Byrne P
    Psychol Med; 2006 Mar; 36(3):353-63. PubMed ID: 16403243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serosorting can potentially increase HIV transmissions.
    Butler DM; Smith DM
    AIDS; 2007 May; 21(9):1218-20. PubMed ID: 17502737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioral interventions to reduce HIV-related sexual risk behavior: review and synthesis of meta-analytic evidence.
    Noar SM
    AIDS Behav; 2008 May; 12(3):335-53. PubMed ID: 17896176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study.
    Badri M; Cleary S; Maartens G; Pitt J; Bekker LG; Orrell C; Wood R
    Antivir Ther; 2006; 11(1):63-72. PubMed ID: 16518961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Bayesian approach to net health benefits: an illustration and application to modeling HIV prevention.
    Johnson-Masotti AP; Laud PW; Hoffmann RG; Hayat MJ; Pinkerton SD
    Med Decis Making; 2004; 24(6):634-53. PubMed ID: 15534344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost effectiveness of a latrine revision programme in Kabul, Afghanistan.
    Meddings DR; Ronald LA; Marion S; Pinera JF; Oppliger A
    Bull World Health Organ; 2004 Apr; 82(4):281-9. PubMed ID: 15259257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimating the value of preventing a human immunodeficiency virus infection.
    Guinan ME; Farnham PG; Holtgrave DR
    Am J Prev Med; 1994; 10(1):1-4. PubMed ID: 8172724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.